Arbabi Bidgoli
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Islamic Azad University, Iran
Sepideh .
Department of Anatomy and Embryology, Tehran University of Medical Sciences, Tehran, Iran
Minaee .
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Bagher .
Department of Pathology,
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Ghahremani .
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
H. Mohammad
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Djamali Zavarhei
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Mansoor .
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Ostad .
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Seyed Nasser
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Fouladdel Shamileh
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
Azizi Ebrahim
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
ABSTRACT
There are controversial data regarding the correlation between gene expression of Thymidylate Synthase (TS) and Thymidine Phosphorylase (TP) with response to chemotherapy and patients’ survival in gastrointestinal malignancies. Therefore, the prognostic role of TS and TP in GI malignancies and in particular, the Esophageal Squamous Cell Carcinoma (ESCC) needs to be more clarified. The TS and TP status in ESCC was determined and correlated molecular alterations with clinicopathological findings. Tumor samples of 30 surgically resected patients were analyzed by immunohistochemical techniques using primary antibodies for TS and TP and Dako labeled Streptavidin-Biotin® 2 (LSAB2) System detection kit. TS and TP were positive in 63.3 and 89.7% of tumor samples, respectively. Unlike TS, expression of TP was correlated with tumor size (p = 0.013). Although the most prevalent immunophenotype was TS+/TP+ (16/30; 53.33%) but the other immunophenotype (TS-/TP+; 10/30; 33.32%) also showed significant relationship with lymphatic invasion (p = 0.035) and histological differentiation (p = 0.001). Despite low number of metastatic cases, four cases out of five had positive expression of both TS and TP in their primary tumor samples. The high TP expression (89.1%) and its established role in tumor angiogenesis could be the reason for its correlation with tumor size and also progression of early stage of ESCC to the advanced stage. Based on present data as well as others, the overexpression of both TS and TP would indicate a poor prognosis for patients with ESCC. On the other hand, our data showed that 36.7 and 10.3% of patients were TS and TP negative, respectively, that obviously affect their response to 5-FU based chemotherapy. In conclusion, the present data showed the importance of TS and TP as valuable prognostic markers that are in correlation with clinicopathological findings.
PDF References
How to cite this article
Arbabi Bidgoli, Sepideh ., Minaee ., Bagher ., Ghahremani ., H. Mohammad, Djamali Zavarhei, Mansoor ., Ostad ., Seyed Nasser, Fouladdel Shamileh and Azizi Ebrahim, 2005. Expression of Thymidylate Synthase and Thymidine Phosphorylase as Prognostic Markers in Advanced Esophageal Squamous Cell Carcinoma. International Journal of Pharmacology, 1: 104-111.
DOI: 10.3923/ijp.2005.104.111
URL: https://scialert.net/abstract/?doi=ijp.2005.104.111
DOI: 10.3923/ijp.2005.104.111
URL: https://scialert.net/abstract/?doi=ijp.2005.104.111
REFERENCES
- Harpole, Jr. D.H., M.B. Moore, J.E. II Herndon, T. Aloia and T.A. D'Amico et al., 2001. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin. Cancer Res., 7: 562-569.
Direct Link - Bidoli, P., S. Aglione, L. Toffolatti, D. de Candis and E. Bajetta, 2002. New strategies in the treatment of esophageal cancer. Minerva Chirurgica, 57: 717-731.
PubMedDirect Link - Catalano, V., A.M. Bladelike, P. Giordani and S. Cascinu, 2001. Molecular markers predictive of response to chemotherapy in gastrointestinal tumors. Crit. Rev. Oncol. Hematol., 38: 93-104.
Direct Link - Fuji, R., A. Seshimo and S. Kameoka, 2003. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int. J. Clin. Oncol., 8: 72-78.
CrossRefDirect Link - Johnston, P.G., H.J. Lenz, C.G. Leichman, K.D. Danenberg, C.J. Allegra, P.V. Danenberg and L. Leichman, 1995. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412.
PubMedDirect Link